However, the scope of these studies was restricted to measuring antibody titers in patients with pure sensory neuropathies or small fiber peripheral neuropathies, which excluded testing FGFR3 antibodies in patients with sensorimotor or motor neuropathies. This evidence concerns the gene FGFR3 and Sensory neuropathy.